Full Press Release Details
Lexicon Pharmaceuticals to Participate in December Investor Conferences.
LXRX
Lexicon Pharmaceuticals to Participate in December Investor Conferences
Key Takeaway: Lexicon Pharmaceuticals to Participate in December Investor Conferences
Price reaction · baseline $0.8634 (2024-11-22 close) · 1 other LXRX headline(s) in the window, move may be shared
day 0 close
-5.8%
day 1
-5%
day 3 · peak
-6.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus